HbA1c variability and all-cause mortality in type 1 and type 2 diabetes: A population-based cohort study using electronic health records
Variability in HbA1c was associated with greater subsequent mortality among people living with diabetes, independent from average HbA1c. Future research should investigate whether reducing HbA1c variability over time in selected patients lowers mortality risk independent of HbA1c level improvements.
Authors
- Iain M. Carey
- Julia Critchley (ORCID: https://orcid.org/0000-0002-5248-4188)
- Elizabeth Limb (ORCID: https://orcid.org/0000-0003-0830-7376)
- Liza Bowen (ORCID: https://orcid.org/0000-0001-8318-8421)
- Arshia Panahloo
- Selma Audi (ORCID: https://orcid.org/0000-0003-2174-7229)
- Stephen DeWilde (ORCID: https://orcid.org/0000-0002-4238-4474)
- Peter H. Whincup (ORCID: https://orcid.org/0000-0002-5589-4107)
- Naveed A. Sattar (ORCID: https://orcid.org/0000-0002-1604-2593)
- Derek G. Cook (ORCID: https://orcid.org/0000-0002-9723-5759)
- Tess Harris (ORCID: https://orcid.org/0000-0002-8671-1553)
- Umar Chaudhry
Institutions
- St George's, University of London (GB)
- St George’s University Hospitals NHS Foundation Trust (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- Diabetes Research and Clinical Practice
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1016/j.diabres.2025.112229
- Citations
- 2
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.59